MICHAEL EMERY: Open Payments
NPI 1215699319 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,017 in 35 payments from 16 companies in 2025. Trend: 2023 $1,151 · 2024 $442 · 2025 $1,017
Food & beverage: $1,017
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 5 | $242 |
| Procept Biorobotics Corporation | 1 | $103 |
| Novo Nordisk Inc | 1 | $96 |
| Janssen Biotech, Inc. | 5 | $84 |
| Antares Pharma, Inc. | 4 | $80 |
| TOLMAR, INC. | 3 | $63 |
| ABBVIE INC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Teleflex LLC | 2 | $48 |
| Boston Scientific Corporation | 2 | $47 |
Products named: XIAFLEX, AVEED, AQUABEAM ROBOTIC SYSTEM, Wegovy, ERLEADA, XYOSTED, ELIGARD, BOTOX.
Industry payments across FL — which companies pay providers there.
